IP Library Assignment 062983/0494
Patent Assignment
Reel/Frame 062983/0494

Security Interest

Recorded: 2023-03-15 Pages: 15
Assignors
BAUSCH HEALTH COMPANIES INC.
Executed: 2022-09-30
VALEANT CANADA LP
Executed: 2022-09-30
VALEANT CANADA GP LIMITED
Executed: 2022-09-30
V-BAC HOLDING CORP.
Executed: 2022-09-30
BAUSCH HEALTH, CANADA INC.
Executed: 2022-09-30
Assignee
THE BANK OF NEW YORK MELLON
240 GREENWICH STREET, SUITE 7E, NEW YORK, NEW YORK, 10286
Covered Properties (11)
Teeth Whitening Composition and Methods
Patent: 8,075,875 →
Application: 11/598,206 →
Publication: US 2007/0128132
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Patent: 7,960,436 →
Application: 11/810,114 →
Publication: US 2008/0146661
N-[2-Amino-4-(Phenylmethoxy)Phenyl] Amides and Related Compounds as Potassium Channel Modulators
Patent: 8,722,929 →
Application: 11/870,368 →
Publication: US 2008/0188561
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Patent: 8,367,684 →
Application: 12/138,251 →
Publication: US 2008/0318979
Naphthyridine Derivatives as Potassium Channel Modulators
Patent: 8,563,566 →
Application: 12/181,126 →
Publication: US 2009/0170885
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Patent: 8,563,604 →
Application: 12/242,681 →
Publication: US 2009/0143333
Photopolymerization Material for Gums Isolation
Patent: 8,334,328 →
Application: 12/525,890 →
Publication: US 2010/0152296
Substituted Arylamino-1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Patent: 8,338,487 →
Application: 13/098,176 →
Publication: US 2011/0207812
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Patent: 8,859,618 →
Application: 14/031,303 →
Publication: US 2014/0023610
Formulations of Calcium and Phosphate for Oral Inflammation
Application: 14/945,865 →
Publication: US 2016/0175356
Compositions and Methods for Teeth Whitening
Patent: 9,655,829 →
Application: 15/006,943 →
Publication: US 2016/0136075
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Change of Name Mar 15, 2019
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES, INC.
Reel/Frame 048609/0729 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Agreement Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Interest Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (Second Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Security Agreement (First Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Change of Name Jan 25, 2023
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 062493/0011 →
Security Interest Feb 13, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062670/0260 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest Apr 14, 2025
From: BARCLAYS BANK PLC
To: BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH COMPANIES INC.
Reel/Frame 070830/0577 →
Change of Name May 1, 2025
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 070996/0143 →
Change of Name May 7, 2025
From: VALEANT PHARMACEUTICALS INTERNATIONAL INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 071053/0649 →
Assignment of Assignor's Interest May 15, 2025
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 071291/0339 →
Assignment of Assignor's Interest May 15, 2025
From: PALEFSKY, IRWIN; WILSON, NI'KITA
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 071125/0976 →
Change of Name May 15, 2025
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 071279/0791 →
Canadian Intellectual Property Security Agreement Jun 13, 2025
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; 1261229 B.C. LTD.; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071566/0056 →
U.S. Patent Security Agreement Jun 13, 2025
From: BAUSCH HEALTH COMPANIES INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0272 →
U.S. Patent Security Agreement Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →